DFS and OS by treatment arm for the adverse cytogenetic risk group. (A) Predicted 5-year DFS was 33% for the HiDAC group (n = 27; red line) and 14% for the multiagent CT group (n = 14; blue line; P = .364). (B) Predicted 5-year OS was 39% for the HiDAC group (n = 27; red line) and 21% for the multiagent CT group (n = 14; blue line; P = .379).